ID | Description | Gene ratio (%) | Bg ratio (%) | Enrich. factora | q-valueb |
---|---|---|---|---|---|
d-1, upregulated | |||||
ko04668 | TNF signaling pathway | 11.56 | 1.37 | 8.44 | 2.06E−11 |
ko04060 | Cytokine-cytokine receptor interaction | 10.98 | 3.19 | 3.45 | 0.000183 |
ko04064 | NF-kappa B signaling pathway | 7.51 | 1.59 | 4.72 | 0.000183 |
ko05144 | Malaria | 4.62 | 0.66 | 7.01 | 0.000626 |
ko05202 | Transcriptional misregulation in cancer | 8.67 | 2.51 | 3.45 | 0.000914 |
ko04621 | NOD-like receptor signaling pathway | 4.62 | 0.76 | 6.09 | 0.001182 |
ko05132 | Salmonella infection | 5.20 | 1 | 5.23 | 0.001182 |
ko05134 | Legionellosis | 4.62 | 0.83 | 5.55 | 0.001781 |
ko04640 | Hematopoietic cell lineage | 5.78 | 1.37 | 4.22 | 0.002204 |
ko05206 | MicroRNAs in cancer | 6.36 | 1.79 | 3.55 | 0.004319 |
ko04933 | AGE-RAGE signaling pathway in diabetic complications | 5.20 | 1.27 | 4.1 | 0.004957 |
ko04010 | MAPK signaling pathway | 8.67 | 3.27 | 2.65 | 0.007215 |
ko04380 | Osteoclast differentiation | 5.78 | 1.67 | 3.47 | 0.007614 |
ko04630 | Jak-STAT signaling pathway | 6.36 | 2.03 | 3.13 | 0.008884 |
ko04066 | HIF-1 signaling pathway | 5.20 | 1.44 | 3.6 | 0.009357 |
ko04920 | Adipocytokine signaling pathway | 4.05 | 0.91 | 4.45 | 0.009608 |
d-1, downregulated | |||||
ko04974 | Protein digestion and absorption | 7.14 | 1.12 | 6.38 | 5.46E−06 |
ko05150 | Staphylococcus aureus infection | 6.63 | 1.06 | 6.27 | 1.07E−05 |
ko04612 | Antigen processing and presentation | 6.12 | 1.18 | 5.18 | 0.000166 |
ko05321 | Inflammatory bowel disease | 5.10 | 0.83 | 6.12 | 0.000166 |
ko05145 | Toxoplasmosis | 6.63 | 1.47 | 4.52 | 0.000166 |
ko04512 | ECM-receptor interaction | 5.61 | 1.05 | 5.37 | 0.000166 |
ko05310 | Asthma | 4.08 | 0.68 | 5.96 | 0.00131 |
ko04672 | Intestinal immune network for IgA production | 4.59 | 0.90 | 5.12 | 0.001329 |
ko04514 | Cell adhesion molecules | 7.14 | 2.13 | 3.36 | 0.001439 |
ko05323 | Rheumatoid arthritis | 5.61 | 1.43 | 3.92 | 0.00198 |
ko05152 | Tuberculosis | 7.65 | 2.53 | 3.03 | 0.002057 |
ko05332 | Graft-versus-host disease | 4.08 | 0.78 | 5.21 | 0.002057 |
ko04640 | Hematopoietic cell lineage | 5.10 | 1.37 | 3.73 | 0.004764 |
ko04940 | Type I diabetes mellitus | 4.08 | 0.91 | 4.49 | 0.004971 |
d-3, upregulated | |||||
ko04713 | Circadian entrainment | 13.89 | 1.19 | 11.62 | 0.004997 |
d-3, downregulated | |||||
ko04974 | Protein digestion and absorption | 18.42 | 1.12 | 16.45 | 1.37E−05 |
ko05144 | Malaria | 10.53 | 0.66 | 15.96 | 0.003842 |
ko05143 | African trypanosomiasis | 10.53 | 0.71 | 14.84 | 0.003842 |
d-7, downregulated | |||||
ko04512 | ECM-receptor interaction | 23.53 | 1.05 | 22.51 | 0.000396 |
ko04974 | Protein digestion and absorption | 23.53 | 1.12 | 21.01 | 0.000396 |
ko04510 | Focal adhesion | 23.53 | 2.60 | 9.05 | 0.00683 |
ko04710 | Circadian rhythm | 11.76 | 0.35 | 33.76 | 0.009739 |
d-10, downregulated | |||||
ko04974 | Protein digestion and absorption | 12.90 | 1.12 | 11.52 | 4.08E−05 |
ko04512 | ECM-receptor interaction | 11.29 | 1.05 | 10.8 | 0.000179 |
ko04932 | Non-alcoholic fatty liver disease | 12.90 | 1.94 | 6.65 | 0.000855 |
ko05010 | Alzheimer’s disease | 12.90 | 2.24 | 5.76 | 0.001788 |
ko00190 | Oxidative phosphorylation | 11.29 | 1.77 | 6.39 | 0.001807 |
ko04151 | PI3K-Akt signaling pathway | 17.74 | 4.62 | 3.84 | 0.001807 |
ko05012 | Parkinson’s disease | 11.29 | 1.84 | 6.13 | 0.001807 |
ko05016 | Huntington’s disease | 12.90 | 2.48 | 5.21 | 0.001807 |